Penile rehabilitation: The evolutionary concept in the management of erectile dysfunction

Current Urology Reports

Volumn 15, Issue 4, 2014, Pages

  Hakky, Tariq S ^a   Baumgarten, Adam S ^a   Parker, Justin ^a   Zheng, Yin ^a   Kongnyuy, Mike ^a   Martinez, Daniel ^a   Carrion, Rafael E ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Erectile dysfunction; Inflatable penile prosthesis; Intracavernosal injections; Penile rehabilitation; Phosphodiesterase inhibitors; Radical prostatectomy

Indexed keywords

COLLAGEN FIBER; PAPAVERINE; PHENTOLAMINE; PHOSPHODIESTERASE V INHIBITOR; PROSTAGLANDIN E1; SILDENAFIL; VASODILATOR AGENT;

ARTICLE; CORPUS CAVERNOSUM; CYSTECTOMY; ERECTILE DYSFUNCTION; FOLLOW UP; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; NONHUMAN; PENIS; PROSTATECTOMY; REHABILITATION CARE; SEXUAL FUNCTION; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; SMOOTH MUSCLE FIBER; UROLOGICAL THERAPEUTIC DEVICE; VACUUM ERECTION DEVICE; CONVALESCENCE; INJECTION; MALE; MALE GENITAL SYSTEM SURGERY; REVIEW; SUPPOSITORY;

ALPROSTADIL; ERECTILE DYSFUNCTION; HUMANS; INJECTIONS; MALE; PENILE IMPLANTATION; PHOSPHODIESTERASE 5 INHIBITORS; PROSTATECTOMY; RECOVERY OF FUNCTION; SUPPOSITORIES; VASODILATOR AGENTS;

EID: 84894291501     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-014-0393-6     Document Type: Article

References (48)

1. Lue TFH. S. Pathophysiology of erectile dysfunction. Campbellwalsh urology. Amsterdam: Elsevier Inc; 2000. p. 668-70.
2. Setter SM, Iltz JL, Fincham JE, Campbell RK, Baker DE. Phosphodiesterase 5 inhibitors for erectile dysfunction. Ann Pharmacother. 2005;39(7-8):1286-95. (Pubitemid 40943182)
3. Budaus L, Huland H, Graefen M. Controversies in the management of localized prostate cancer: radical prostatectomy still the standard of care. Crit Rev Oncol Hematol. 2012;84 Suppl 1:e24-9.
4. Stanford JL, Feng Z, Hamilton AS, Gilliland FD, Stephenson RA, Eley JW, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA: J Am Med Assoc. 2000;283(3):354-60. (Pubitemid 30051753)
5. Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD, et al. 5-year urinary and sexual outcomes after radical prostatectomy: results from the Prostate Cancer Outcomes Study. J Urol. 2008;179(5 Suppl):S40-4. (Pubitemid 351483914)
6. Hu JC, Elkin EP, Pasta DJ, Lubeck DP, Kattan MW, Carroll PR, et al. Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol. 2004;171(2 Pt 1):703-7. doi:10.1097/01.ju.0000107964.61300.f6. discussion 7-8.
7. Eilat-Tsanani S, Tabenkin H, Shental J, Elmalah I, Steinmetz D. Patients' perceptions of radical prostatectomy for localized prostate cancer: a qualitative study. Israel Med Assoc J: IMAJ. 2013;15(3): 153-7.
8. Kendirci M, Bejma J, Hellstrom WJ. Update on erectile dysfunction in prostate cancer patients. Curr Opin Urol. 2006;16(3):186-95. (Pubitemid 43791789)
9. Kury P, Stoll G, Muller HW. Molecular mechanisms of cellular interactions in peripheral nerve regeneration. Curr Opin Neurol. 2001;14(5):635-9. (Pubitemid 32964584)
10. Leungwattanakij S, Bivalacqua TJ, Usta MF, Yang DY, Hyun JS, Champion HC, et al. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl. 2003;24(2):239-45.
11. Segal R, Burnett AL. Erectile preservation following radical prostatectomy. Ther Adv Urol. 2011;3(1):35-46.
12. •• Mulhall JP, Parker M, Waters BW, Flanigan R. The timing of penile rehabilitation after bilateral nerve-sparing radical prostatectomy affects the recovery of erectile function. BJU Int. 2010;105(1):37-41. This paper examined the timing of penile rehab.
13. Iacono F, Giannella R, Somma P, Manno G, Fusco F, Mirone V. Histological alterations in cavernous tissue after radical prostatectomy. J Urol. 2005;173(5):1673-6. (Pubitemid 40524802)
14. User HM, Hairston JH, Zelner DJ, McKenna KE, McVary KT. Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol. 2003;169(3): 1175-9. (Pubitemid 36188196)
15. Gontero P, Fontana F, Bagnasacco A, Panella M, Kocjancic E, Pretti G, et al. Is there an optimal time for intracavernous prostaglandin E1 rehabilitation following nonnerve sparing radical prostatectomy? Results from a hemodynamic prospective study. J Urol. 2003;169(6):2166-9. (Pubitemid 36576740)
16. Mosbah A, El Bahnasawy M, Osman Y, Hekal IA, Abou-Beih E, Shaaban A. Early versus late rehabilitation of erectile function after nerve-sparing radical cystoprostatectomy: a prospective randomized study. J Sex Med. 2011;8(7):2106-11.
17. Raina R, Pahlajani G, Agarwal A, Zippe CD. Early penile rehabilitation following radical prostatectomy: cleveland clinic experience. Int J Impot Res. 2008;20(2):121-6. (Pubitemid 351374319)
18. Kuthe A. Phosphodiesterase 5 inhibitors in male sexual dysfunction. Curr Opin Urol. 2003;13(5):405-10. doi:10.1097/01.mou.0000088747.16181.4b. (Pubitemid 37094288)
19. Alwaal A, Al-Mannie R, Carrier S. Future prospects in the treatment of erectile dysfunction: focus on avanafil. Drug Des Dev Ther. 2011;5:435-43.
20. Carrier S, Zvara P, Nunes L, Kour NW, Rehman J, Lue TF. Regeneration of nitric oxide synthase-containing nerves after cavernous nerve neurotomy in the rat. J Urol. 1995;153(5):1722-7.
21. •• Yamashita S, Kato R, Kobayashi K, Hisasue S, Arai Y, Tsukamoto T. Nerve injury-related erectile dysfunction following nerve-sparing radical prostatectomy: a novel experimental dissection model. Int J Urol: Off J Japan Urol Assoc. 2009;16(11):905-11. This is one of the few ground-breaking rat models.
22. Sirad F, Hlaing S, Kovanecz I, Artaza JN, Garcia LA, Rajfer J, et al. Sildenafil promotes smooth muscle preservation and ameliorates fibrosis through modulation of extracellular matrix and tissue growth factor gene expression after bilateral cavernosal nerve resection in the rat. J Sex Med. 2011;8(4):1048-60.
23. Facio Jr F, Burnett AL. Penile rehabilitation and neuromodulation. Sci World J. 2009;9:652-64.
24. Yuan J, Hoang AN, Romero CA, Lin H, Dai Y, Wang R. Vacuum therapy in erectile dysfunction-science and clinical evidence. Int J Impot Res. 2010;22(4):211-9.
25. Klein LT, Miller MI, Buttyan R, Raffo AJ, Burchard M, Devris G, et al. Apoptosis in the rat penis after penile denervation. J Urol. 1997;158(2):626-30. (Pubitemid 27327736)
26. Ferrini MG, Davila HH, Kovanecz I, Sanchez SP, Gonzalez-Cadavid NF, Rajfer J. Vardenafil prevents fibrosis and loss of corporal smooth muscle that occurs after bilateral cavernosal nerve resection in the rat. Urology. 2006;68(2):429-35. (Pubitemid 44175524)
27. Schwartz EJ, Wong P, Graydon RJ. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol. 2004;171(2 Pt 1):771-4. (Pubitemid 38090480)
28. Padma-Nathan H, McCullough AR, Levine LA, Lipshultz LI, Siegel R, Montorsi F, et al. Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res. 2008;20(5):479-86.
29. Montorsi F, Brock G, Lee J, Shapiro J, Van Poppel H, Graefen M, Stief C. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol. 2008;54(4):924-31.
30. Bannowsky A, Schulze H, van der Horst C, Hautmann S, Junemann KP. Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil. BJU Int. 2008;101(10):1279-83. (Pubitemid 351549634)
31. Aydogdu O, Gokce MI, Burgu B, Baltaci S, Yaman O. Tadalafil rehabilitation therapy preserves penile size after bilateral nerve sparing radical retropubic prostatectomy. Int Braz J Urol Off J Braz Soc Urol. 2011;37(3):336-44. discussion 44-6.
32. Lee DJ, Cheetham P, Badani KK. Penile rehabilitation protocol after robot-assisted radical prostatectomy: assessment of compliance with phosphodiesterase type 5 inhibitor therapy and effect on early potency. BJU Int. 2010;105(3):382-8.
33. Zippe CD, Pahlajani G. Vacuum erection devices to treat erectile dysfunction and early penile rehabilitation following radical prostatectomy. Curr Urol Rep. 2008;9(6):506-13.
34. Basal S, Wambi C, Acikel C, Gupta M, Badani K. Optimal strategy for penile rehabilitation after robot-assisted radical prostatectomy based on preoperative erectile function. BJU Int. 2013;111(4): 658-65.
35. Yuan J, Lin H, Li P, Zhang R, Luo A, Berardinelli F, et al. Molecular mechanisms of vacuum therapy in penile rehabilitation: a novel animal study. Eur Urol. 2010;58(5):773-80.
36. •• Montorsi F, Guazzoni G, Strambi LF, Da Pozzo LF, Nava L, Barbieri L, et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol. 1997;158(4):1408-10. This paper first started the paradigm of penile rehab.
37. Raina R, Pahlajani G, Agarwal A, Jones S, Zippe C. Long-term potency after early use of a vacuum erection device following radical prostatectomy. BJU Int. 2010;106(11):1719-22.
38. Kohler TS, Pedro R, Hendlin K, Utz W, Ugarte R, Reddy P, et al. A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy. BJU Int. 2007;100(4): 858-62. (Pubitemid 47360201)
39. Shen YJ, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, et al. [Penile rehabilitation with vacuum erection device for erectile dysfunction after radical prostatectomy]. Zhonghua nan ke xue Natl J Androl. 2012;18(8):723-6.
40. •• Sellers T, Dineen M, Salem EA, Wilson SK. Vacuum preparation, optimization of cylinder length and postoperative daily inflation reduces complaints of shortened penile length following implantation of inflatable penile prosthesis. Adv Sex Med. 2013;3:14-8. This paper is a ground breaking regarding the use of VED to place a larger penile implant.
41. Lehrfeld T, Lee DI. The role of vacuum erection devices in penile rehabilitation after radical prostatectomy. Int J Impot Res. 2009;21(3):158-64.
42. McCullough AR, Hellstrom WG, Wang R, Lepor H, Wagner KR, Engel JD. Recovery of erectile function after nerve sparing radical prostatectomy and penile rehabilitation with nightly intraurethral alprostadil versus sildenafil citrate. J Urol. 2010;183(6):2451-6.
43. Montague DK, Jarow JP, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, et al. Chapter 1: the management of erectile dysfunction: an AUA update. J Urol. 2005;174(1):230-9.
44. Mydlo JH, Volpe MA, MacChia RJ. Results from different patient populations using combined therapy with alprostadil and sildenafil: predictors of satisfaction. BJU Int. 2000;86(4):469-73.
45. .• Nehra A, Blute ML, Barrett DM, Moreland RB. Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Int J Impot Res. 2002;14 Suppl 1:S38-42. This paper examined the role of combination therapy in the treatment of penile rehab. (Pubitemid 34215249)
46. Mulhall J, Land S, Parker M, Waters WB, Flanigan RC. The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med. 2005;2(4):532-40. discussion 40-2.
47. Chung E, Brock G. Sexual rehabilitation and cancer survivorship: a state of art review of current literature andmanagement strategies in male sexual dysfunction among prostate cancer survivors. J Sex Med. 2013;10 Suppl 1:102-11.
48. Mulhall JP, Bivalacqua TJ, Becher EF. Standard operating procedure for the preservation of erectile function outcomes after radical prostatectomy. J Sex Med. 2013;10(1):195-203.